NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Michael Dobelbower, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana A. Leal, Rogerio Lilenbaum, Jules Lin, Billy W. LooRenato Martins, Gregory A. Otterson, Sandip P. Patel, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt Tauer, Stephen C. Yang, Kristina Gregory, Miranda Hughes

Research output: Contribution to journalReview articlepeer-review

186 Scopus citations

Abstract

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

Original languageEnglish (US)
Pages (from-to)807-821
Number of pages15
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN guidelines <sup>®</sup> insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this